The U.S. Food and Drug Administration on Wednesday amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 vaccines to authorize updated boosters to combat the omicron variant.
FDA authorizes updated COVID-19 boosters to combat omicron variant
